The U.S. Anti-Doping Agency announced on Monday that UFC athlete Daniel Omielanczuk, of Warsaw, Poland, has tested positive for a prohibited substance, which was determined to have been ingested by him without fault or negligence in accordance with the World Anti-Doping Agency (WADA) guidance concerning meldonium.
Omielanczuk, 34, tested positive for meldonium as the result of an out-of-competition urine sample he provided on January 21, 2016. Meldonium is a non-specified substance that was added to the WADA Prohibited List in 2016. It is in the category of Hormone and Metabolic Modulators and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the WADA Prohibited List.
During USADA’s investigation of the case, Omielanczuk presented evidence establishing that his use of meldonium was limited to a three-week span, from mid-August to early September 2015. Omielanczuk and his advisors confirmed that Omielanczuk did not resume his use of the substance after September 2015 because they became aware that the substance would be added to the WADA Prohibited List in 2016, and subsequently banned under the UFC Anti-Doping Program.
TRENDING > Stipe Miocic Set to Defend Heavyweight Title at UFC 211
After a thorough review of the case, USADA concluded that the extremely low meldonium concentration in the athlete’s urine sample, combined with the available documentary evidence and the athlete’s explanation of use, was consistent with ingestion prior to the substance being officially prohibited on January 1, 2016. Accordingly, based on the results management guidance offered by WADA for cases involving meldonium, Omielanczuk will not face a period of ineligibility for his positive test.
Omielanczuk is slated to return to the Octagon opposite Timothy Johnson at UFC Fight Night 107 on March 18 in London.
(Photo courtesy of UFC)
Follow MMAWeekly.com on Facebook, Twitter and Instagram